Kiran Amancha,Chandeshwari Chilampalli,Thrimoorthy Potta,Ningxin Yan,Venkat R. Goskonda
申请号:
US15876553
公开号:
US20180147143A1
申请日:
2018.01.22
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.